Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $744.05 | 38 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $135.47 | 8 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $123.16 | 6 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $97.05 | 7 | $0 (2017) |
| Avanir Pharmaceuticals, Inc. | $92.38 | 1 | $0 (2017) |
| Lilly USA, LLC | $77.23 | 4 | $0 (2018) |
| GlaxoSmithKline, LLC. | $40.16 | 2 | $0 (2018) |
| Amgen Inc. | $39.50 | 2 | $0 (2017) |
| HOLOGIC INC | $29.37 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $19.38 | 1 | $0 (2017) |
| Abbott Laboratories | $17.86 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $14.19 | 1 | Novo Nordisk Inc ($14.19) |
| 2018 | $125.53 | 7 | Novo Nordisk Inc ($31.78) |
| 2017 | $604.33 | 30 | SANOFI-AVENTIS U.S. LLC ($123.16) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/13/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Diabetes | ||||||
| 08/25/2018 | West-Ward Pharmaceuticals | Mitigare (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/11/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: VACCINES | ||||||
| 04/26/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Respiratory | ||||||
| 03/16/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Diabetes | ||||||
| 02/14/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug), ADACEL | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: VACCINES | ||||||
| 01/18/2018 | Lilly USA, LLC | HUMULIN (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Diabetes | ||||||
| 01/04/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Obesity | ||||||
| 12/07/2017 | PFIZER INC. | VIAGRA (Drug), CHANTIX, ELIQUIS | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 12/06/2017 | Abbott Laboratories | FreeStyle Libre blood glucose Flash Monitoring System (Device), FreeStyle Libre blood glucose Flash Monitoring System, FreeStyle Libre blood glucose Flash Monitoring System | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Diabetes Care | ||||||
| 11/21/2017 | GlaxoSmithKline, LLC. | BEXSERO (Biological), MENVEO, SHINGRIX | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: VACCINES | ||||||
| 10/26/2017 | Novo Nordisk Inc | Levemir (Drug), Tresiba, Victoza | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Diabetes | ||||||
| 09/14/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Diabetes | ||||||
| 08/24/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/23/2017 | Lilly USA, LLC | HUMULIN (Drug), HUMALOG, TRULICITY | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Diabetes | ||||||
| 08/21/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: Endocrinology | ||||||
| 08/10/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Endocrinology | ||||||
| 07/13/2017 | HOLOGIC INC | ThinPrep (Device) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: Diagnostics | ||||||
| 07/06/2017 | Lilly USA, LLC | HUMALOG (Drug), TRULICITY | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Diabetes | ||||||
| 06/22/2017 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/08/2017 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/25/2017 | Lilly USA, LLC | HUMULIN (Drug), HUMALOG, TRULICITY | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Diabetes | ||||||
| 05/11/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Diabetes | ||||||
| 04/13/2017 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/27/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 86 | 94 | $13,154 | $7,509 |
| 2022 | 5 | 90 | 107 | $14,535 | $8,648 |
| 2021 | 4 | 91 | 102 | $14,263 | $9,087 |
| 2020 | 5 | 87 | 90 | $10,397 | $5,605 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 30 | 30 | $5,790 | $4,211 | 72.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 21 | $3,936 | $1,822 | 46.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 19 | $2,444 | $980.69 | 40.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 24 | 24 | $984.00 | $495.84 | 50.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 40 | $7,120 | $3,840 | 53.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 22 | 22 | $4,246 | $3,048 | 71.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 14 | $1,694 | $998.40 | 58.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $696.00 | $383.09 | 55.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 19 | 19 | $779.00 | $378.76 | 48.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 29 | 29 | $5,597 | $4,252 | 76.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 40 | $7,120 | $4,055 | 56.9% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 16 | 16 | $560.00 | $453.92 | 81.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 17 | 17 | $986.00 | $326.23 | 33.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 26 | 26 | $5,018 | $3,356 | 66.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 18 | $3,204 | $1,168 | 36.5% |
| 90756 | Vaccine for influenza for injection into muscle | Office | 2020 | 17 | 17 | $445.00 | $444.13 | 99.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 17 | 17 | $986.00 | $321.94 | 32.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 11 | 12 | $744.00 | $314.34 | 42.3% |
About Dr. Elizabeth Iskander, M.D
Dr. Elizabeth Iskander, M.D is a Internal Medicine healthcare provider based in Monrovia, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1831382191.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elizabeth Iskander, M.D has received a total of $744.05 in payments from pharmaceutical and medical device companies, with $14.19 received in 2020. These payments were reported across 38 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($744.05).
As a Medicare-enrolled provider, Iskander has provided services to 354 Medicare beneficiaries, totaling 393 services with total Medicare billing of $30,848. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Monrovia, CA
- Active Since 08/21/2007
- Last Updated 12/17/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1831382191
Products in Payments
- APTIOM (Drug) $97.05
- ONZETRA Xsail (Drug) $92.38
- SOLIQUA (Drug) $64.90
- HUMULIN (Drug) $60.65
- PRALUENT (Drug) $58.26
- Levemir (Drug) $58.05
- Prolia (Biological) $39.50
- Ozempic (Drug) $32.77
- Victoza (Drug) $31.45
- ThinPrep (Device) $29.37
- SHINGRIX (Biological) $21.97
- JANUVIA (Drug) $19.38
- BEXSERO (Biological) $18.19
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $17.86
- Mitigare (Drug) $17.45
- HUMALOG (Drug) $16.58
- FLUZONE HIGH-DOSE (Drug) $16.05
- SYMBICORT (Drug) $14.63
- Saxenda (Drug) $13.20
- VIAGRA (Drug) $12.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Monrovia
Dr. Nandar Swe, Md, MD
Internal Medicine — Payments: $2,353
Mika Ohtomo, M.d, M.D
Internal Medicine — Payments: $207.55
Karen Kim, Md, MD
Internal Medicine — Payments: $145.27
Dr. David Ku, M.d, M.D
Internal Medicine — Payments: $39.74
Mr. Cheng Yeh, Md, MD
Internal Medicine
Dr. David Comings, M.d, M.D
Internal Medicine